Therapy Areas: Inflammatory Diseases
15 October 2021 - - The first patient has been dosed in US-based cancer immunotherapy company Immune-Onc Therapeutics, Inc's first-in-human clinical trial of IO-108, a novel antagonist antibody t...
15 October 2021 - - US-based Amber Specialty Pharmacy will begin dispensing Tavneos (avacopan), a first of its kind orally-administered selective complement 5a receptor inhibitor, as an adjunctive tre...
15 October 2021 - - US-based Exelixis, Inc. (NASDAQ: EXEL) has exercised its exclusive option under its July 2019 agreement with Aurigene Discovery Technologies Ltd. to in-license XL114 (formerly...
12 October 2021 - - US-based digital health solutions company Quanterix Corp's (NASDAQ: QTRX) Simoa phospho-Tau 181 (pTau-181) blood test has been granted Breakthrough Device designation by ...
12 October 2021 - - A manuscript describing US-based biopharmaceutical company Humanigen, Inc's (NASDAQ: HGEN) budget impact model for the treatment of patients hospitalized with COVID-19 is avai...
12 October 2021 - - The US Food and Drug Administration has approved US-based biopharmaceutical company Ocular Therapeutix, Inc's (NASDAQ: OCUL) Supplemental New Drug Application to broaden the D...
Related Headlines